Sirpiglenastat: A Diazoketone-Containing Prodrug Clinical Candidate
sirpiglenastat
IV/SC glutamine antimetabolite prodrug Ph. I/IIa in advanced solid tumors dual prodrug of natural product Sci. Adv., 16 November 2022 Johns Hopkins / Dracen Pharmaceuticals